Net Deals Web Search

  1. Ad

    related to: alcon pharmaceuticals inc news

Search results

  1. ALC - Alcon Inc.

    Yahoo Finance

    89.43-0.33 (-0.37%)

    at Fri, May 24, 2024, 4:00PM EDT - U.S. markets closed

    Delayed Quote

    • Open 89.66
    • High 89.97
    • Low 89.34
    • Prev. Close 89.76
    • 52 Wk. High 91.08
    • 52 Wk. Low 69.44
    • P/E 42.38
    • Mkt. Cap 44.24B
  2. Results From The WOW.Com Content Network
  3. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.

  4. Alcon Laboratories is considering a major $100M expansion of ...

    www.aol.com/alcon-laboratories-considering-major...

    Alcon, which started in Fort Worth and has grown to become the world’s largest eye care device company, is looking to invest an estimated $100 million to build a 250,000-square-foot ...

  5. Novartis chairman says Alcon worth $20 billion -$30 ... - AOL

    www.aol.com/news/novartis-chairman-says-alcon...

    The chairman of Swiss drugmaker Novartis (NOVN.S) expects Alcon to be valued at between $20 billion (15.14 billion pounds) and $30 billion when the opthalmic devices unit is spun off to ...

  6. Aerie Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Aerie_Pharmaceuticals

    In August 2022, Swiss eye-care firm Alcon agreed to buy Aerie Pharmaceuticals for US$770 million. The acquisition completed in November 2022. References

  7. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    It is also the second-largest pharmaceutical company by market cap in 2019. Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity.

  8. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    More than two years after beginning the acquisition process, Swiss pharmaceutical company Novartis said Thursday that it has finally completed the purchase of a 77% majority stake in U.S....

  9. Novartis' (NVS) Alcon Acquired PowerVision for $285 Million - AOL

    www.aol.com/news/novartis-nvs-alcon-acquired...

    Novartis' (NVS) eye-care unit, Alcon acquires PowerVision to drive growth in advanced technology intraocular lenses (AT-IOLS) for cataract surgery patients.

  10. Gilead Sciences - Wikipedia

    en.wikipedia.org/wiki/Gilead_Sciences

    Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

  11. Allergan - Wikipedia

    en.wikipedia.org/wiki/Allergan

    Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. [1] [2] [3] The company is the maker of Botox.

  12. Regeneron Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Regeneron_Pharmaceuticals

    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...